current user: public

anford Burnham Prebys Medical Discovery Institute
We are hiring bioinformatics experts and software developers. Join us!

Query: 3s2k_A mol:protein length:629 Low-density lipoprotein receptor-related prot, from PDB0516

Results of FFAS03 search in PDB0516
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .
# Score Template Links and tools%idFirst ADPEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQSGWNECASSNGHCSHLCLAVPVGGFVCGCPAHYSLNADNRTCSAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAIVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELNLQEYRQHPCAQDNGGCSHICLVKGDGTTRCSCPMHLVLLQDELSCGEPLast
1 -175.0003s2k_A mol:protein length:629 Low-density lipoprotein receptor-related prot  ali model  100  1ADPEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQSGWNECASSNGHCSHLCLAVPVGGFVCGCPAHYSLNADNRTCSAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAIVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELNLQEYRQHPCAQDNGGCSHICLVKGDGTTRCSCPMHLVLLQDELSCGEP 619
2 -165.0003s8v_A mol:protein length:623 Low-density lipoprotein receptor-related prot  ali model follow..  100  2..PEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQSGWNECASSNGHCSHLCLAVPVGGFVCGCPAHYSLNADNRTCSAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAIVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELNLQEYRQHPCAQDNGGCSHICLVKGDGTTRCSCPMHLVLLQDELSC... 615
3 -162.0004a0p_A mol:protein length:628 LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROT  ali model follow..  99  3GVPEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQSGWNECASSNGHCSHLCLAVPVGGFVCGCPAHYSLNADNRTCSAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAVVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELNLQEYRQHPCAQDNGGCSHICLVKGDGTTRCSCPMHLVLLQDELSCGGT 621
4 -141.0003s94_A mol:protein length:619 Low-density lipoprotein receptor-related prot  ali model follow..  40  1...APLLLYANRRDLRLVDATNGKENATIVVGGLEDAAAVDFVFSHGLIYWSDVSEEAIKRTEFNKTESQNVVVSGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVLFWQELDQPRAIALDPSSGFMYWTDWGEVPKIERAGMDGSSRFIIINEIYWPNGLTLDYEEQKLYWADAKLNFIHKSNLDGTNRQAVVKSLPHPFALTLFEDILYWTDWSTHSILACNKYTGEGLREIHSDIFSPMDIHAFSQQRQPATNPCGIDNGGCSHLCLMSPVKFYQCACPTGVKLLENGKTCDGATELLLLARRTDLRRISLDTPDFTDIVLQLEDIRHAIAIDYDPVEGYIYWTDDEVRAIRRSFIDGSGSQFVVTAQI------AHPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTMRKILISEDLEEPRAIVLDPMVGYMYWTDWGE-IPKIERAALDGSDRVVLVNTSLGWPNGLALDYDEGKIYWGDAKTDKIEVMNTDGTGRRVLVEDKIPHIFGFTLLGDYVYWTDWQRRSIERVHKRSAEREVII-DQLPDLMGLKATNVHRVI--GSNPCAEENGGCSHLCLYRP-QGLRCACPIGFELISDMKTCIVP 611
5 -89.3003v64_C mol:protein length:349 agrin  ali model follow..  29  1......................................................................................................................................................................................................................................................................VNECA-EEGYCSQGCTNSE-GAFQCWCEAGYELRPDRRSCKGPEPVLLFANRIDIRQVLPHRSEY---TLLLNNLENAIALDFHHRRELVFWSDVTLDRILRANLNGSNVEEVVSTGL------ESPGGLAVDWVHDKLYWTDSGTSRIEVANLDGAHRKVLLWQSLEKPRAIALHPMEGTIYWTDWGNT-PRIEASSMDGSGRRIIADTHLFWPNGLTIDYAGRRMYWVDAKHHVIERANLDGSHRKAVISQGLPHPFAITVFEDSLYWTDWHTKSINSANKFTGKNQEIIRNKLHFPMDIHTLHPQRQPA-GKNRCGDNNGGCTHLCLPSG-QNYTCACPTGFRK-INSHACAL. 343
6 -86.2003v65_B mol:protein length:386 Low-density lipoprotein receptor-related prot  ali model follow..  27  29........................................................................................................................................................................................................................................................HTGYRLTEDGRTCQDVNECAEEGYCSQGCTNSE-GAFQCWCEAGYELRPDRRSCKAPEPVLLFANRIDIRQVLPHRSEYT---LLLNNLENAIALDFHHRRELVFWSDVTLDRILRANLNGSNVEEVVSTGL------ESPGGLAVDWVHDKLYWTDSGTSRIEVANLDGAHRKVLLWQSLEKPRAIALHPMEGTIYWTDWGNT-PRIEASSMDGSGRRIIADTHLFWPNGLTIDYAGRRMYWVDAKHHVIERANLDGSHRKAVISQGLPHPFAITVFEDSLYWTDWHTKSINSANKFTGKNQEIIRNKLHFPMDIHTLHPQRQP-AGKNRCGDNNGGCTHLCLPSGQN-YTCACPTGFRK-INSHACAQ. 386
7 -83.7003soq_A mol:protein length:318 Low-density lipoprotein receptor-related prot  ali model follow..  44  1AGSAPLLLYANRRDLRLVDATNGKENATIVVGGLEDAAAVDFVFSHGLIYWSDVSEEAIKRTEFNKTESQNVVVSGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVLFWQELDQPRAIALDPSSGFMYWTDWGEVPKIERAGMDGSSRFIIISEIYWPNGLTLDYEEQKLYWADAKLNFIHKSNLDGTNRQAVVKSLPHPFALTLFEDILYWTDWSTHSILACNKYTGEGLREIHSDIFSPMDIHAFSQQRQPNTNPCGIDNGGCSHLCLMSPKPFYQCACPTGVKLLENGKTCKDGNS........................................................................................................................................................................................................................................................................................................................ 312
8 -67.5003m0c_C mol:protein length:791 Low-density lipoprotein receptor  ali model follow..  28  392VGSIAYLFFTNRHEVRKMTLDRSEYTSLI--PNLRNVVALDTEVASNRIYWSDLSQRMICSTQLDRSSYDTVISRDIQAPDGLAVDWIHSNIYWTDSVLGTVSVADTKGVKRKTLFRENGSKPRAIVVDPVHGFMYWTDWGTPAKIKKGGLNGVDIYSLVTNIQWPNGITLDLLSGRLYWVDSKLHSISSIDVNGGNRKTILEDLAHPFSLAVFEDKVFWTDIINEAIFSANRLTGSDVNLLAENLLSPEDMVLFHNLTQPRCERTTLSNGGCQYLCLPAPSPKFTCACPDGMLLARDMRSCLTEAEAAVATQETSTVRLKVSSTAVRTQTRPVPDTSRLPGATPGLTTVEIVTMSHQALGDVAGRGNEKKPSSV.................................................................................................................................................................................................................................................... 784
9 -65.9001npe_A mol:protein length:267 nidogen  ali model follow..  34  2....THLLFAQTGKIERLPLERNTMKKAFLHIPAKVIIGLAFDCVDKVVYWTDISEPSIGRASLHGGEPTTIIRQDLGSPEGIALDHLGRTIFWTDSQLDRIEVAKMDGTQRRVLFDTGLVNPRGIVTDPVRGNLYWTDWNDNPKIETSHMDGTNRRILAQNLGLPNGLTFDAFSSQLCWVDAGTHRAECLNPAQPGRRKVLEGLQYPFAVTSYGKNLYYTDWKTNSVIAMDLAISKEMDTFHPHQTRLYGITIALSQCPQG..................................................................................................................................................................................................................................................................................................................................................................... 266
10 -32.0003s25_A mol:protein length:302 Hypothetical 7-bladed beta-propeller-like pro  ali model follow..  11  2.................................................................................................................................................LNSSYVNGNTAGNLYNA-------LFCESDGEVFFSNTNDNRLYAMNIDGSNIHKLSND--TAMYINADKNYVYYVRNNNQKITSQTFFSYDR----------------------------------------------------------------------------NSLCRIKRNGHGSTV-------LDPDPCIYASLIGNYIYYLHYDTQSLYRIRIDGEEKKKIKNHYL-----------FTCNTSDRYFYYNNPKNGQLYRYDTASQSEALFYDCNCYKP----VVLDDTNVYYMDVNRDN-AIVHVNINNPNPVVLTEANIEHYNVYG----SLIFYQRGGDNPALCVVKNDGTGFKELAKG---EFCNINVTSQYVYFTDFVSNKEYCTSTQNPDTIKALQ................................................................ 301
11 -27.2003wwa_A mol:protein length:298 Pizza7H protein  ali model follow..  21  5.................................................................SNTQTVLPFTGLNTPNGVAVD--AGTVYVTDHGNNRVVKLAAGSNTQTVLPFTGLNTPNGVAVDS-AGTVYVTDHGNN-RVVKLAAGSNTQTVLFTGLNTPNGVAVD-SAGTVYVTDHGNNRVVKLAAGSNTQTVLFTGLNTPNGVAV--------------------------------------------------------------------------------------------------------------------------------------SAGTVYVTDHGNNRVVKLAAGSNTQTVLPFTGLN------TPNGVAVD--AGTVYVTDHGNNRVVKLAAGSNTQTVLPFTGLNTPNGVAVDS-AGTVYVTDHGNN--RVVKLAAGSNTQTVLPFTGLNTPNGVAVD-SAGTVYVTDHGNNRVVKLA.................................................................................................................... 296
12 -25.0002z2p_A mol:protein length:299 VIRGINIAMYCIN B LYASE  ali model follow..  14  1......................................................................................................................................................MEFKLQELLTNQDTGPYGITVS-DKGKVWITQHKANMISCINLDGKTEYELPNKGAKVMCLTI-DGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITE---------------------------------------------------------------------------------------------PNGDIWFTEMNGNRIGRITDDGKIREYELPNK------GSYPSFITLG--DNALWFTENQNNAIGRITESGDITEFKIPTPASGPVGITKGN-DDALWFVEII--GNKIGRITTSGEITEFKIPTPNARPHAITAG-AGIDLWFTEWGANKIGRLTSNNIIEEYPIQIKSAEPAGICFDGETIWFAMEC-DKIGKLTLIKD....................................................................... 296
13 -24.9002z2n_A mol:protein length:299 virginiamycin B lyase  ali model follow..  14  1......................................................................................................................................................MEFKLQELLTNQDTGPYGITVS-DKGKVWITQHKANMISCINLDGKTEYPLPTPDAKVMCLTI-DGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITE---------------------------------------------------------------------------------------------PNGDIWFTEMNGNRIGRITDDGKIREYELPNK------GSYPSFITLG--DNALWFTENQNNAIGRITESGDITEFKIPTPASGPVGITKGN-DDALWFVEII--GNKIGRITTSGEITEFKIPTPNARPHAITAG-AGIDLWFTEWGANKIGRLTSNNIIEEYPIQIKSAEPHGICFDGETIWFAM-ECDKIGKLTLIKD....................................................................... 296
14 -24.1002qc5_A mol:protein length:300 Streptogramin B lactonase  ali model follow..  14  4....................................................................................................................................................AWMNFYLEEFLSIPDSGPYGITSS-EDGKVWFTQHKANKISSLDQSGRKEFEVPTPDAKVMCLIV-LGDIWFTENGANKIGKLSKKGGFTEYPLPQPDSGPYGITE---------------------------------------------------------------------------------------------LNGDIWFTQLNGDRIGKLTADGTIYEYDLPNK------GSYPAFITLG--DNALWFTENQNNSIGRITNTGKLEEYPLPTNAAAPVGITSGN-DGALWFVEIM--GNKIGRITTTGEISEYDIPTPNARPHAITAG-KNSEIWFTEWGANQIGRITNDNTIQEYQLQTENAEPHGITF-DGSVWFALKCKIGKLNLNE.......................................................................... 300
15 -22.9001rwi_B mol:protein length:270 Serine/threonine-protein kinase pknD  ali model follow..  21  21.....................................................................................................................DFRLSPSGVAVDS-AGNVYVTSEGMYGRVVKLATGSTGTTVLFNGLYQPQGLAVD-GAGTVYVTDFNNRVVTLAAGSNNQTVLPFDGLNYPEGLAV--------------------------------------------------------------------------------------------------------------------------------------TQGAVYVADRGNNRVVKLAAGSKTQTVLPFTGLN------DPDGVAVD--SGNVYVTDTDNNRVVKLEAESNNQVVLPFTDITAPWGIAVDE-AGTVYVTEHNTN--QVVKLLAGSTTSTVLPFTGLNTPLAVAVD-SDRTVYVADRGNDRVVKLT.................................................................................................................... 261
16 -21.6004yzu_B mol:protein length:62 Coagulation factor IX  ali model follow..  29  3.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEP. 43
17 -20.6001rfn_B mol:protein length:57 PROTEIN (COAGULATION FACTOR IX)  ali model follow..  30  2..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEP. 41
18 -19.1002gd4_L mol:protein length:58 Coagulation factor X, Stuart factor, Stuart-P  ali model follow..  27  3.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KLCSLDNGDCDQFCHEEQ-NSVVCSCARGYTLADNGKACIP. 42
19 -18.6003bws_A mol:protein length:433 protein Lp49  ali model follow..  10  1...........................................................................................MLESSGDFSLLSSPINREKNGTEIVKFSI-HPYKGTVIRLGEEILFKVLEMDKNIALVEMAIPVYKDEKEIELKLSSPGFQNSSYRIRKPEELNEKLIALDKEGITHRFISR--FQPKSVRFIDNRLAIPLLEDEGMDVLDINSGQTVRLSPPE-KYKKKLGFVETISIPEHNELWVSQMQANAVHVFDLKTLAYKA-SKILLYDPIRDL--------VYCSNWISEDISVIDRKTKLEIRKTDKIGLPRGLLLSKDGKELYIAQFSASNQESGGGRLGIYSMDKEKLIDTIGPPGNKRHIVSGNTENKIYVSDMCCSKIEVYDLKEKKVQKSIPVF-DKPNTIALSPDGKYLYVSCRGPNHPT---YVIDTTTDTVKEFWEANQPTGLDVSPDNRYLVISDFLDHQIRVYRRDG................................................................................................................. 426
20 -18.4003kl6_B mol:protein length:57 Coagulation Factor X light chain  ali model follow..  27  5.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KLCSLDNGDCDQFCHEEQ-NSVVCSCARGYTLADNGKACIP. 44
21 -18.1001kig_L mol:protein length:51 FACTOR XA  ali model follow..  42  1...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................CSLDNGGCDQFCREER-SEVRCSCAHGYVLGDDSKSCVS. 38
22 -18.0003vgz_A mol:protein length:353 Uncharacterized protein YncE  ali model follow..  11  5...................................................................................HLFSSRLRGSLLLGSLLVVSSFSTQAAEEMLRKAVG-KGAYEMAYSQQENALWLATSQSRKLDKGGVLDPVTLEVTIHNDLKPFGATINNTTQTLWFGNTVNSAVTAIDAKTGEGRLVLDDRKRTEEVRPLQPRELVADDATNTVYISGIGKESVIWVV--------------------------------------------------------------------------------DGGNIKLKTAIQNTGKMSTGLALDSEGKRLYTTNADGELIT---IDTADNKILSRKKLLDDGKEHFFINISLDTARQRAFITDSKAAEVLV--VDTRNGNILAKVAAPESLAVLFNPARNEAYVTHRQAGKVSV----IDAKSYKVVKTFDTTHPNSLALSADGKTLYVSVKQKSTKQQEATQPDDVIRI........................................................................................................... 351
23 -17.9001l0q_A mol:protein length:391 Surface layer protein  ali model follow..  12  1.............................................STFAYIANSESDNISVIDVTSNKVTATIPVG-SNPMGAVISPDGTKVYVANAHSNDVSIIDTATNNVIATVPAG-SSPQGVAVSPDGKQVYVTNMASS-TLSVIDTTSNTVAGTVKTGKSPLGLALSPDGKKLYVTNNGDKTVSVINTVTKAVINTVSVGRSPKGIAV-GTKVYVANFDSMSISVIDTVTNSVIDTVKVEAA------------------------------------------PSGIAVNPEGTKA------YVTNVDKYFNTVSMIDTGTNKITARIPVGPDPAGIAVTPDGKKVYVALSFCNTVSVIDTATNTITATMAVG-------KNPYASGQFIGSIPVQPVYPSADFKSNITSGYIFLSEPVQFT-DGSSSKKQNPTHTYSETGIYTVRLTVS----NSNGTDSQISTVNVLKGSPTP.......................................................................................................................................... 390
24 -17.7002ra0_L mol:protein length:51 Coagulation factor X  ali model follow..  28  2...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................CSLDNGDCDQFCHEEQ-NSVVCSCARGYTLADNGKACIP. 39
25 -17.7003fvz_A mol:protein length:329 Peptidyl-glycine alpha-amidating monooxygenas  ali model follow..  13  16................................LPGQVSGVALD-SKNNLVIFHRGDHVWDGNSFDSKFVYQQ-KNLFYLPHGLSID--DGNYWVTDVALHQVFKLDPHSKEGPLLIQNHFCQPTDVAVEPSTGAVFVSDGYCNSRIVQFSPSGKFVTQW-GQFSVPHSLALVPHLDQLCVADRENGRIQCFKTDTKEFVREIKAISYIPGFLF-NGKPYFGDQEPVQGFVMNFSSGEIIDVFRKHFDMPHDIVASEDGT........................................................................................................................................................................................................................................................................................................................................................................ 298
26 -17.3003u4y_A mol:protein length:331 uncharacterized protein  ali model follow..  6QTTSNFGIVVEQHLRRISFFSTDTLEILNQITLGYDFVDTAITSDCSNVVVTSDFCQTLVQIETQLEPPKVVAIQEGQSMADVDITPDDQFAVTVTGLNHPFNMQSYSFLKNKFISTIPIYDAVGIAISPNGNGLILIDRSSANTVRRFKIDADGGQEFISGGTRPFNITFTPDGNFAFVANLIGNSIGILETQNPENITLLNAVNLPGTIVVSRDTVYVLTESTVDVFNFNQLSGT.............................................................................................................................................................................................................................................................................................................................................................................................. 254
27 -17.0003hrp_A mol:protein length:409 Uncharacterized protein  ali model follow..  10  2.........SDDNKTTGATYDPNQPVTVESFMPVEGKLREKVI-VKGSNFGTDKSKVKVYFVDEAAERLSTVIGID------------NNTLY-APRQLPGGNRIKVIVDGKEVTTDGTFKYEQAQNVSTISG----------SASKDGNDDGDLAS---AKFKYMWGIAAV-GNNTVLAYQRDDPRVRLISVDDNKVTTVHPGKQRVYSIGW-THTVYVYMKASGWAPTRIGQLGS-------------------------------------------------------------------------------------------------TFSGKIGAVALDETEEWLYFVDSNKNFGRFNVKTQEVTLIKQLELSGSLGTNPGPYLIYYF--DSNFYMSDQNLSSVYKITPDGECEWFC-EALFAQPNGMTVDE-DGNFYIVD-GFKGYCLRKLDILDGYVSTVAEATFNYPYDICYD-GEGGYWIAEAWGKAIRKYAVE.................................................................................................................. 409
28 -16.9003qqz_A mol:protein length:255 Putative uncharacterized protein yjiK  ali model follow..  10  26.................................TNNISSLTWSAQSNTLFSTINKPAAIVEMTTNGDLIRTIPLDFVKDLETIEYI--DNQFVISDERDYAIYVISLTPNSEVKILKPTNCGFEGLAYSRQDHTFWFFKEKNPIEVYKLHISKDKALQRQFTLDDVSGAEFNQQKNTLLVLSHESRALQEVTLVGEVIGEMSHNIKQAEGVAMDASGNIYIVSEPNRFYRFTPQSSH.............................................................................................................................................................................................................................................................................................................................................................................................. 255
29 -16.3001uzj_A mol:protein length:162 FIBRILLIN-1  ali model follow..  19  1....................................................................................................................................................................................................................................................................TDVNECLDPTTCISGNCVNTP-GSYICDCPPDFELNPTRVGCVD----------------------------------------------------------------------------------------------------------------------------------------------TRSGNCYLDIRPRGDNGDTA-------CSNEIGVGVSKAS-----CSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILED------------------------------------------IDECQELPGLCQGKCINTF-GSFQCRCPTGYYLNEDTRVCD.. 162
30 -16.0002fpb_A mol:protein length:322 Strictosidine Synthase  ali model follow..  12  1................SLALSSPILKEILIEAPSYAPNSFTFDSTNKGFY-TSVQDGRVMKYEGPNSGFVDFAYAS-GRTYDISYNLQNNQMYIVDCYYHLSVVGSEGGHATQLATSVDFKWLYAVTVDQRTGIVYFTDVSTLGRLMKYDPSTKETTLLMKELHVPGGAEVSADSSFVLVAEFLSHQIVKYWLEGKGTAEVLVKIPNPGNIKRNADGHFWVSSSEELDGNMHGRVDPKGIKFDEFGNILEVIPLPPPFAGEHFEQIQEHDG............................................................................................................................................................................................................................................................................................................................................................ 294
31 -15.9002fp8_A mol:protein length:322 Strictosidine synthase  ali model follow..  12  1................SLALSSPILKEILIEAPSYAPNSFTFDSTNKGFY-TSVQDGRVIKYEGPNSGFVDFAYAS-GRTYDISYNLQNNQLYIVDCYYHLSVVGSEGGHATQLATSVDFKWLYAVTVDQRTGIVYFTDVSTLGRLIKYDPSTKETTLLLKELHVPGGAEVSADSSFVLVAEFLSHQIVKYWLEGKGTAEVLVKIPNPGNIKRNADGHFWVSSSEELDGNMHGRVDPKGIKFDEFGNILEVIPLPPPFAGEHFEQIQEHDG............................................................................................................................................................................................................................................................................................................................................................ 294
32 -15.8002dg0_A mol:protein length:333 DrP35  ali model follow..  12  54............................................RQGQLFLLDVFEGNIFKINPETKEIKRPFVSHKANPAAIKIHKDGRLFVCYLGDFKSIFAATENGDNLQDIIEDTAYCIDDMVFDS-KGGFYFTDFRPLGGVYYVSPDFRTVTPIIQNISVANGIALSTDEKVLWVTETTANRLHRIALEDDGVTIYFTGHEGPDSCCI-DDNLYVAMYGQGRVLVFNKRGYPIGQILIPGRDEGHMLRSTHPQFIPGTNQLIICSNDIEM........................................................................................................................................................................................................................................................................................................................................................ 303
33 -15.6005ex7_A mol:protein length:286 Brain tumor protein  ali model follow..  16  28................................QFTEPSGVAVN-AQNDIIVADTNNHRIQIFDKEGRFKFQF-DSQLLYPNRVAVVRNSGDIIVTESPTHQIQIYNQYGQFVRKFGATILQHPRGVTVDN-KGRIIVVECKVM-RVIIFDQNGNVLHKF-KHLEFPNGVVVN-DKQEIFISDNRAHCVKVFNYEGQYLRQIGGETNYPIGVGI-NGEILIADNHNNFNLTIFTQDGQLISALKVKHAQCFDVALMDDGS........................................................................................................................................................................................................................................................................................................................................................................ 263
34 -15.5001q7f_A mol:protein length:286 brain tumor CG10719-PA  ali model follow..  16  28................................QFTEPSGVAVN-AQNDIIVADTNNHRIQIFDKEGRFKFQF-DSQLLYPNRVAVVRNSGDIIVTESPTHQIQIYNQYGQFVRKFGATILQHPRGVTVDN-KGRIIVVECKVM-RVIIFDQNGNVLHKF-KHLEFPNGVVVN-DKQEIFISDNRAHCVKVFNYEGQYLRQIEGITNYPIGVGI-NGEILIADNHNNFNLTIFTQDGQLISALKVKHAQCFDVALMDDGS........................................................................................................................................................................................................................................................................................................................................................................ 263
35 -15.5003kya_A mol:protein length:496 Putative phosphatase  ali model follow..  2.........KDDDNVETGAFDPSKPVAISDFTPKEGGAYQKL-LIYGENFGTDVSKVKVKIGGKDAI----------------VINVKSTYVYCFVPSGAFSGEIEITVGEGENAVTTTASTTFSYEKKMVVGTLCGYRNNRDDQGWRDGPFDGPEGVKCCGFSDNGRLAFDPLNKHLYICYDGHKAIQLIDLKNRMLSSPLNINKKIEGYADEAEYMIVAIDYDGKGDES--------------------------------------------------------------------------------PSVYIIKRNADGTFDDRSDIQLIAAYKQCNGATIHPINGELYFNSYEKGQVFRLDLVDYFKTIKNGGSLFTIADPSWEFQIFIHPTGKYAYFGVINNHYFMRSDYDGYRDDVGTEARMNNPCQGVFVKEEYDFYFVDRLNF--CVRKVTPEGIVSTYAEVARFRDVSGLVYDDVKEMFYVHDQVGHTIRTISMEQEEN.............................................................................................................. 478
36 -14.6003gcw_E mol:protein length:83 Low-density lipoprotein receptor  ali model follow..  30  6.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NECLDNNGGCSYVCNDLK-IGYECLCPDGFQLV-AQRRCED. 44
37 -14.5001apq_A mol:protein length:53 COMPLEMENT PROTEASE C1R  ali model follow..  32  5.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DECASRSKSCQHLCHNYV-GGYFCSCRPGYELQEDRHSCQ.. 51
38 -14.5004hw6_A mol:protein length:433 hypothetical protein, IPT/TIG domain protein  ali model follow..  4...............................LDVNQDSGTPFNPKEEIVV-----------LPTEGRKGTRVVVYG----RNFGNDVSKVKVTIGGYPAKVINV---KGESLLCICPSKAYEGDVKVSVVGDDEAELKSGVCEAKFD-TTFLGKLYEDDCGAFDNIWRMMFDPNSNDDLYWVGQRDAFRHVDFVNQYVDIKTTNIGQCADVNF-NGDMVVVDDQSSDTNTG--------------------IYLFTRASGFTERLSLCNARGAKTCAVHPQNGKI----------------------YYTRYHHAMISSYDPATGTLTEEEVMMDTKGSNFHIVWHPTGDWAYIIYNGKHCIYRVDYNRETGKLAVPWGPNQGIFVKNEAYAGEE--EYDFYFCDRDSHTVRVLTPEGRVTTYA--------------------------GRGNSREWGYVDGELRS---QALFNHPTSIAYDMKRKCFYIGDCDNHRVRKIAPE.................................................................................................................. 432
39 -14.4003li5_A mol:protein length:314 Diisopropyl-fluorophosphatase  ali model follow..  14  1.................MEIPVIEPLFTKVTEDIPGAQGPVFDKNGDFYIVNGKPAGEILRIDLKTGKKTVICKPEVGIPAGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIAKKDRMQGCDDCAFDY-EGNLWITAPAKFGSIYCFTTDGQ-MIQVDTAFQFPDGIAVDGRPYQLIVAETPTKKLWSYDIKGPAKHIPGTHEGGANGMDF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPSNLHFKPQTKTIFVTEHENNA............................................................................................................................................................................................................................................................................................................................................................. 291
40 -14.2002w2m_E mol:protein length:107 LOW-DENSITY LIPOPROTEIN RECEPTOR  ali model follow..  33  24.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NECLDNNGGCSHVCNDLK-IGYECLCPDGFQL-VAQRRCED. 62
41 -14.2001e1a_A mol:protein length:314 DIISOPROPYLFLUOROPHOSPHATASE  ali model follow..  14  1.................MEIPVIEPLFTKVTEDIPGAEGPVFDKNGDFYIVNGKPAGEILRIDLKTGKKTVICKPEVGIPAGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIAKKDRMQGCNDCAFDY-EGNLWITAPAKFGSIYCFTTDGQ-MIQVDTAFQFPNGIAVDGRPYQLIVAETPTKKLWSYDIKGPAKHIPGTHEGGADGMDF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPSNLIFVTEHENNAVWKFEWQRNGKKQYCETLKFGIF.............................................................................................................................................................................................................................................................................................................................................. 314
42 -14.0003i1c_A mol:protein length:324 Diisopropyl-fluorophosphatase  ali model follow..  15  1.................MEIPVIEPLFTKVTEDIPGAAGPVFDKNGDFYIVNGKPAGEILRIDLKTGKKTVICKPEVGIPIGCQCDRDANQLFVADMRLGLLVV-QTDGTFEEIAKKDRMQGCAYCAFDY-EGNLWITAPAKFGSIYCFTTDGQ--IQVDTAFQAPAGIAVDGRPYQLIVAEQPTKKLWSYDIKGENKKVWGHHKGGAAGMDF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPSALHFKPQTKTIFVTEHENNA............................................................................................................................................................................................................................................................................................................................................................. 291
43 -13.8003hlh_A mol:protein length:314 Diisopropyl-fluorophosphatase  ali model follow..  14  1.................MEIPVIEPLFTKVTEDIPGAEGPVFDKNGDFYIVNGKPAGEILRIDLKTGKKTVICKPEVGIPAGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIAKKDRMQGCNDCAFDY-EGNLWITA-EKFGSIYCFTTDGQ-MIQVDTAFQFPNGIAVDGRPYQLIVAEMPTKKLWSYDIKGPAKHIPGTHEGGADGMDF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPSNLIFVTEHENNAVWKFEWQRNGKKQYCETLKFGIF.............................................................................................................................................................................................................................................................................................................................................. 314
44 -13.7003tc9_A mol:protein length:430 Hypothetical hydrolase  ali model follow..  10  15.........NKPVVISEFSPKEGGLGTRMLLYGENSKIKVTIGGQDSKVVGAKGKSLYCVVPAKAYDGDIKLSILNDEGEEIANTEANEKFVYQKKMLVTTFLGTMYDGNTKYFDDCGGFGGAVWLSFDPKNHNHLYLVGEQH-PTRLIDFEKEYVSTVYSGLSKVRTICWTHEADSMIITNDQNNNDRPNNYI-VITELTKGQNCNGAETHPINGELYFNSWNAGQVFRYDFTTQETTPLFTIQDSGWEFHIQFHPSGNY--------------------------------------------------------------------AYIVVVNQHYILRSDYDWKTKRLTTPYIVCGQQGAKDWVDGVGKKARMHAPRQGTFVKNPAYKGSS--EYDFYFCDRENHCIRILTPQGRVTTFA-------------------------GRGSNGTSGYNDGDLRQEA----RFNHPEGIVYDEERECFFIGDRENRRIRKIGYE.................................................................................................................. 429
45 -13.6004o5t_A mol:protein length:337 Diisopropyl-fluorophosphatase  ali model follow..  14  31............................FYVVASPLSEALINANSLAEAYEARSDAGEILHIDLKTGKKTVICKPEVGSPIGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIANKRCMQGCAYCAFDY-EGNLWITAPAKFGSIYCFTTDGQ--IQVDTAFQCPAGIAVRHMNDQLIVAEQPTKKLWSYDIKGENKKVWGHHKGGAAGMVF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPANLHFKPQTKTIFVTEHDNNA............................................................................................................................................................................................................................................................................................................................................................. 304
46 -13.4005c2v_B mol:protein length:352 HYDRAZINE SYNTHASE BETA SUBUNIT  ali model follow..  2.......................YIQGTHVKTDLPGPFHITMSPDGSTLFISNQSGHSVTFVDARTQKVTGEVAVR-VQPEASAVTPDGAFLYVCNAESDSVSVVDIQRKQEIKEIKVG-DWPSGIKISPDGKTAYVACSGCMWN-AIDVIDTGRMEKVRSSDYGPRMVEISPDGKTLV-VGSINRSVDFIDIASGRENRVIHESSNLRDVVY-GKYIAVTHQTPKNWLPVCE--------AENGQVFTNNVTIIETKAGGKVAR------------LPLDDLNNYDGNPYGMAMDPKGKY--------LYIGVRGMHRVTILDMDKVLGLVRSSTQEELDYLRDD--------LGLVRDYLVARVPTGLG-----------------PSSVCLSPDGKFCYAANYFSNNVTVIRTAVD........................................................................................................................................................................................................ 352
47 -13.2002p4o_A mol:protein length:306 hypothetical protein  ali model follow..  10  40.APDGTIFVTNHEVGEIVSITPDGNQQIHATVE-GKVSGLAFT-SNGDLVATGWNADSIPVVSLDGTVETLLTLPDAIFLNGITPL--DTQYLTADSYRGAIWLIDVVQPSGSIWLEHESVFPAANGLKRFGNFLYVSNTEKM-LLLRIPVDSTDKPEIFVEQTNIDDFAFD-VEGNLYGATHIYNSVVRIAPDRSTTIIAQQGVIGSTAVAF-CTAIYVVTNGGMFLPPPTGVVPANVVRLEVGKP.................................................................................................................................................................................................................................................................................................................................................................................... 301
48 -13.2001z6c_A mol:protein length:87 Vitamin K-dependent protein S  ali model follow..  21  4.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DECSLKPSICTAVCKNIP-GDFECECPEGYRYNLKSKSCED. 44
49 -13.2003u0s_A mol:protein length:337 Diisopropyl-fluorophosphatase  ali model follow..  15  31............................FYIVASPLSEALTKANSPAEAYKASRGAGEILRIDLKTGKKTVICKPEVGSPIGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIAKKDRMQGCAYCAFDY-EGNLWITAPAKFGSIYCFTTDGQ--IQVDTAFQCPAGIAVDGRPYQLIVAEQPTKKLWSYDIKGENKKVWGHHKGGAAGMDF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPANLHFKPQTKTIFVTEHENNA............................................................................................................................................................................................................................................................................................................................................................. 304
50 -13.1001sqj_A mol:protein length:789 oligoxyloglucan reducing-end-specific cellobi  ali model follow..  25KTKDLLYARTDIGGAYRWDAGTSKWIPLNDFIEAQDTESIALDPNNPDRLYLGDEWAAFYVSEDRGQSFTIY-DMGRNNGERLAVNPFNSNEVWMGTRTEGIWKSSDRAKTWTNVTFTNGIGYTSVIFDPERNGTIYASATAPQGMYVTHDGGVSWEPVAGQPSS-CGLSVDATNPNRLVVITALDSIYLSTDAGATWKDVTQLSSPSNLEGNFNNGPQWGGYGAPHGTPGLTKFGWWMSAVLIDPFNPEHLMYGTGATIWATDTLSRVEKD---------WAPSWYLQIDGIEENAILSLRSPKSGAALLSGIGDISGMKHDDLTKPQKMFGAPQFSNLDSIDAAGNFPNVVVRASACARGAYATDGGDAWTIFPTCPPGMNASHYQGSTIAVDASGSQIVWSDEQASGPWYSHDYGKTWSVPAGDLKAQTANVLSDKVQDGTFYA---TDGGKFFVSTDGGKSYAAKGAGVTGTSLMPAVNPWVAGDVWVPVPEGGLFHSTDFGASFTRVGTANATLVSVGAPKSKSDGKKASAPSAVFIWGTDKPGSDIGLYRSDDNGSTWTRVNDQEHNYSGPTMIEADPKVYGRVYLGTNGRGIVYADLTNKKSNEEKST.... 773
51 -13.0001ri6_A mol:protein length:343 putative isomerase ybhE  ali model follow..  11  2..................................................................................................................................SLKQTVYIASPESQQIHVWNLNHEGALTLTQVVDQVQPMVVSPDKRYLYVGVRPEFRVLAYRIAPDDGALTFAAESALPGSLTH------TDHQGQFVFVGSYNAG-------------------------------------------------------------------------------NVSVTRLEDGLPVGVVDVVEGLDGCHSANISPDNRTLWVPALKQDRICLFTVSDDGHLVAQDPAEVTTVEGAGPRHMVFHPNEQYAYCVNELNSSVDVWELKDPHGNIECVQTLDMAADIHITPDGRHLYACDRTASLITVFSVSEDGSVLSKEGFQPTTQPRGFNVDHSGKYLIAAGQKSHHISVYEIVGLLHEKGRYAVGQGPMWVVVNA............................................................................................ 332
52 -13.0001aut_L mol:protein length:114 ACTIVATED PROTEIN C  ali model follow..  41  49...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................QREVSFLNCSLDNGGCTHYCLEEV-GWRRCSCAPGYKLGDDLLQCHP. 94
53 -13.0001lmj_A mol:protein length:86 fibrillin 1  ali model follow..  17  30................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DEGYESGFMMMKNCMDIDECQRDPLLCRGGVCHNTEGSYRCECPPGHQLSPNISAC... 85
54 -12.9001b9w_A mol:protein length:95 PROTEIN (MEROZOITE SURFACE PROTEIN 1)  ali model follow..  20  43.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PAPNMTCKDKNGGCAPECKMNDKNEIVCKCTKEGSEPLEGVFCS.. 89
55 -12.8002w86_A mol:protein length:147 FIBRILLIN-1  ali model follow..  27  93........................................................................................................................................................................................................................................................GKGYSRIKGTQCEDIDECEVFPGVCKNLCVNTR-GSFKCQCPSGMTLDATGRICL............................................................................................................................................................................................................................................................................................................................ 147
56 -12.8004o5s_A mol:protein length:337 Diisopropyl-fluorophosphatase  ali model follow..  14  31............................FYVVASPLSEALTKANSPAEAYKASRGAGEILHIDLKTGKKTVICKPEVGSPIGCQCDRDANQLFVADMRLG-LLVVQTEGTFEEIAKKRCMQGCAYCAFDY-EGNLWITAPAKFGSIYCFTTDGQ--IQVDTAFQCPAGIAVRHMNDQLIVAEQPTKKLWSYDIKGENKKVWGHHKGGAAGMVF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPANLHFKPQTKTIFVTEHDNNA............................................................................................................................................................................................................................................................................................................................................................. 304
57 -12.8002npr_A mol:protein length:90 Merozoite surface protein 1  ali model follow..  22  44.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PASNVTCKDNNGGCAPECKMTDSNKIVCKCTKEGSPLFEGVFCS.. 90
58 -12.7005fkq_A mol:protein length:733 ENDO-1,4-BETA-GLUCANASE/XYLOGLUCANASE, PUTATI  ali model follow..  11  1.................MAPSENYTWKNVRIDGGGFVPGIIFNQKEADLIYARTAIGGAYRWNSATSSWIPLLNWGWNGVMSLATDAADPNRVYADPNNGAILRSTDRGNTWQAT-MPGRGMGERLAIDPNRNSIIYYGAEGGNGLWRST-DYGATWAKVSSFTNGGNYAQDPNDPNDYLNKITQNAIYRSTDGGTTWSRLTGFLPHKGVYDAVNGVLYIADGAKGDVWKFTASSGTWTNISPIPSSSSDLYFGYSGLTIDRKNPNTLMVASQIA----WPDAVFFRSTNGGASWTRWDWTSYPSRSFRYTMDITEVPWLNFGNSNPVAPEVSPKLGWMNESVEIDPHNSNRLMYGTGATIYATENLTSWDSGGQILLKPMVKGLEETAVLDVVS--GAPVYSALGDIGGFRHDDLTKVPTSMYTTPNFSSTTSIDFAELQATMVRVGNLDSGGGIGVTTNAGGSWWQGQNPGVTSGGNVALAADGGAIVWAPGGSTNVYLSTTFGSTWTAISALPAGAVIEADRVNPNKFYA--LANGTFYVSTNKGASFSATVTA.............................................................. 601
59 -12.7001dx5_I mol:protein length:118 THROMBOMODULIN  ali model follow..  17  5.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DPCF--RANCEYQCQPLDQTSYLCVCAEGFAPIPEPHRCQM. 44
60 -12.7001dqb_A mol:protein length:83 THROMBOMODULIN  ali model follow..  20  6.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DPCF--RANCEYQCQPLNQTSYLCVCAEGFAPIPHEPRCQM. 45
61 -12.6002h3x_A mol:protein length:390 Aromatic Amine Dehydrogenase  ali model follow..  2.........................................................................................KSKFKLTTAAAMLGLMVLAGGAQAQDKPREVLTGGHSVSAPQENRIYVMDSVFMHLTESR-YDYTNGKFLGMPTAFNGHVQVSNDGKKIYTMTTYHERITRGKRSDV--------------VEVWD---------------------------ADKLTFEKEISLPPKRVQGLNY-------------------------DGLFRQTTDGK-------FIVLQNASPATSIGIVDVAKGDYVEDVTAAAGCWSVIPQPNRPRSFMTICGDGGLLTINLGEDGKVASQSRSKQMFSVKDDPIFIAPALDKDKAHFVSYY-GNVYSADFSGDEVKVDGPWSLLNDEDVGLHRASGRMYVFMHPDGKEGTHKFPMDTKTKQRVARIPGRDALSMTIDQQRNLMLTLDGGNVNVYDISQPEPKLLRTIEGAAEASLQVQFHPV........................................................................................... 387
62 -12.5005chb_A mol:protein length:87 nvPizza2-S16H58  ali model follow..  29  4........................................................................MFTGLNTPSGVAVD--AGTVYVTDHGNNRVVKLAAGSNTQTVLPFTGLNTPHGVAVDS-AGTVYVTDHGNN-RVVKLAAGSNTQTVL............................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 87
63 -12.4004zcn_A mol:protein length:87 nvPizza2-S16S58  ali model follow..  22  4........................................................................................................................................................................................................................................................................................................................................................................................................................................MFTGLNTPSGVAVDS-AGTVYVTDHGNN--RVVKLAAGSNTQTVLPFTGLNTPSGVAVD-SAGTVYVTDHGNNRVVKLAAGSNTQTVL........................................................................................................... 87
64 -12.3003gis_X mol:protein length:121 Thrombomodulin  ali model follow..  17  5.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DPCF--RANCEYQCQPLNQTSYLCVCAEGFAPIPEPHRCQL. 44
65 -12.3001dan_L mol:protein length:152 BLOOD COAGULATION FACTOR VIIA light chain  ali model follow..  31  89.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTP. 129
66 -12.3001n1i_A mol:protein length:105 Merozoite surface protein-1  ali model follow..  25  51................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SITCEENNGGCAPECTMDDKKEVECKCTKEGSPLFEGVFCSSP 99
67 -12.3001z1y_A mol:protein length:186 ookinete surface protein Pvs25  ali model follow..  10  1...................................................................................................................................................................................................................................................................EAEASAVTVDTICKNGQLVQMS-NHFKCMCNEGLVH-LSENTCEEKNECKKETLGKAC----------------------------------------------------------------------------------------------------GEFGQCIENPDPAQVNMYKCGCIEG-----------------------------------------------YTLKEDTCVLDVCQYKNCGESGECIVEYLSEIQ--------------------------------SAGCSCAIGKVPNPEDEKKCTKTGETACQLKCNNEVCKNVE-GVYKCQCMEGFTFDKEKNVCLGP 180
68 -12.1004mzv_A mol:protein length:248 Epithelial cell adhesion molecule  ali model follow..  2.......................................................................................................................................................................................................................................................................EECVCENYKLAVNC--FVNNNRQCQCTNTVICSKLAAKCLVMKAEMQGSKLGRRAKPEGALQNNDGLYDPDCDESGLFKAKQCQGTSTCWCVNTAGVRRTDKDTEITCSERVRTYWIIIELKHKAREKPY----DSKSLRTALQKEITTRYQLDPKFITSILYENNVITIDLVQQSSQKTQNDVDIADVAYYFEKDVKGESLFHSKKMDLTVNGEQLDLDPGQTLIYYVDEKAPEFSMQGLK.................................................................................................................. 242
69 -12.0002p9w_A mol:protein length:334 Mal s 1 allergenic protein  ali model follow..  12  15....................................PEDTIYDRTRQVFYQSNLYKGRIEVYNPKTQSHFNVVIDGASSNGSLLTHDNSKRLFAVMKNAKSFNFADQSSHGASSFHSFNLPLVVQSAQDR-DGNSYVAFALGMPAIARVSADGKTVSTFAWQRPGYSGITFD-PHSNKLIAFGGPRALTAFDVSKPYAWPEPVKINGDFGTVPVGNESVLVGARAPYAISFRSWDNWKSANIKKTKRS................................................................................................................................................................................................................................................................................................................................................................................... 277
70 -11.9004lgn_A mol:protein length:749 Cellulose-binding, family II  ali model follow..  1.................MATTQPYTWSNVAIGGGGFVDGIVFNEGAPGILYVRTDIGGMYRWDAANGRWIPLLNWGYNGVVSIAAD--TNKVWAADPNDGAILRSSDQGATWQIT-MPGRGMGERLAVDPNNDNILYFGAPSGKGLWRSTDSGATWSQMTNDIQGVVWVAFDKSSSSLGQASKTINPVFWSRDGGATWQAVPGAPTGFIPFDPVNHVLYIADGSSGDVWKFSVTSGTWTRI--SPVPSTDTANDYFGYSGLTIDRQHPNTIMVATQISWWPDTIIFRSTDGGATWTRIWDWTSYPNRSLRYVLDISAEPWLTFGVQPNPPVPSPKLGWMDEAMAIDPFNSDRMLYGTGATLYATNDLTKWDSGGQIHIAPMVKGLEETVNDLISPPSGAPLISALGDLGGFTHADVTAVPSTIFTSPVFTTGTSVDYAELNPSIIVRAGSFDDRHVAFSTDGGKNWFQGSEPGVTTGGTVAASADGSRFVWAPGDPGQPVVYAVGFGNSAQIRSDRVNPKTFYALSNGTFYRSTVTFQPVAAGLPSSGAVGVMFHAVPGKEGDLWL..................................................... 630
71 -11.8001cej_A mol:protein length:96 PROTEIN (MEROZOITE SURFACE PROTEIN 1)  ali model follow..  24  43.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ENPNPTCNENNGGCDAKCTEEDGKKITCECTKPDSYPLDGIFCSS. 94
72 -11.6001jof_A mol:protein length:365 CARBOXY-CIS,CIS-MUCONATE CYCLASE  ali model follow..  11  4.....................................................................................................................................HLMIGTWTPPGAIFTVQFDDEKLTCEIPQDEPISWMTFDHERKNIY------------------------------GAAMKKWSSFAVKSPTEIVHEASHPIGGHPRANDADTNTRAIFLLAAKQPPYAVYANPFYKFA---------------------------------------GYGNVFSVSETGKLEKNVQNYEYQENTGIHGMVFDPTETYLYSADLTANKLWTHRKLASGEVELVGSVDAPDP--DHPRWVAMHPTGNYLYALMEAGNRICEYVIDPATHMPV-GKGLYRADVCALTFSGKYMFASSRANKFEAGFKLRDCGSIEKQLTPTSGGHSNAVSPCPWSDEMAITDDQEGWLEIYRWKDEFLHRVARVRIPEPGFGM----NAIWYD..................................................................................... 365
73 -11.5001emn_A mol:protein length:82 FIBRILLIN  ali model follow..  18  45.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DECSVGNPCGNGTCKNVI-GGFECTCEEGFEP-GPMMTCE.. 82
74 -11.5001ob1_C mol:protein length:99 MAJOR MEROZOITE SURFACE PROTEIN  ali model follow..  25  43.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ENPNPTCNENNGGCDAKCTEEDSKKITCECTKPDSYPLDGIFCS.. 93
75 -11.5002mgp_A mol:protein length:99 Merozoite surface protein 1  ali model follow..  21  50.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PTCDINNGGCDPSCQNAESKKIICTCKEPTPNAYEGVFCSS. 97

FFAS is supported by the NIH grant R01-GM087218-01
1 1 6 5 6 4   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Jaroszewski L, Rychlewski L, Zhang B, Godzik A. Fold prediction by a hierarchy of sequence, threading, and modeling methods. Protein Sci. 1998 Jun;7(6):1431-40.